Investigation of Suicidality and Psychological Adverse Events in Patients Treated With Finasteride
Authors:
Open Access
- 1 January 2021
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Dermatology
- Vol. 157 (1) , 35-42
Abstract
Concerns have emerged about the adverse effects of finasteride, a drug indicated for the management of both male-pattern baldness (androgenetic alopecia)1,2 and benign prostatic hyperplasia (BPH).3-5 Reports of suicidality and psychological adverse events related to finasteride have led to coining of the term postfinasteride syndrome and the creation of organizations such as the Post-Finasteride Syndrome Foundation.6-10 In 2011, a postmarketing report was sent to the US Food and Drug Administration suggesting that finasteride may be linked to depression, self-harm, and suicide.11 In the last 5 years, health authorities in Canada, Korea, New Zealand, and the United Kingdom have also acknowledged these potential adverse effects and issued warnings for finasteride.12-15Keywords
This publication has 40 references indexed in Scilit:
- EAU Guidelines on the Treatment and Follow-up of Non-neurogenic Male Lower Urinary Tract Symptoms Including Benign Prostatic ObstructionEuropean Urology, 2013
- Benefits and strengths of the disproportionality analysis for identification of adverse drug reactions in a pharmacovigilance databaseBritish Journal of Clinical Pharmacology, 2011
- Persistent Sexual Side Effects of Finasteride for Male Pattern Hair LossThe Journal of Sexual Medicine, 2011
- Adverse Side Effects of 5α-Reductase Inhibitors Therapy: Persistent Diminished Libido and Erectile Dysfunction and Depression in a Subset of PatientsThe Journal of Sexual Medicine, 2011
- S1 guideline for diagnostic evaluation in androgenetic alopecia in men, women and adolescentsBritish Journal of Dermatology, 2010
- Quantitative signal detection using spontaneous ADR reportingPharmacoepidemiology and Drug Safety, 2009
- Application of Quantitative Signal Detection in the Dutch Spontaneous Reporting System for Adverse Drug ReactionsDrug Safety, 2003
- Non‐sedating antihistamine drugs and cardiac arrhythmias – biased risk estimates from spontaneous reporting systems?British Journal of Clinical Pharmacology, 2002
- Bayesian Data Mining in Large Frequency Tables, with an Application to the FDA Spontaneous Reporting SystemThe American Statistician, 1999
- Social Support and the Outcome of Major DepressionThe British Journal of Psychiatry, 1989